[HTML][HTML] Clinical perspective on topical vaccination strategies
Vaccination is one of the most successful measures in modern medicine to combat
diseases, especially infectious diseases, and saves millions of lives every year. Vaccine …
diseases, especially infectious diseases, and saves millions of lives every year. Vaccine …
Chikungunya virus: priority pathogen or passing trend?
G Montalvo Zurbia-Flores, A Reyes-Sandoval, YC Kim - Vaccines, 2023 - mdpi.com
Chikungunya virus (CHIKV) is considered a priority pathogen and a major threat to global
health. While CHIKV infections may be asymptomatic, symptomatic patients can develop …
health. While CHIKV infections may be asymptomatic, symptomatic patients can develop …
RBD and spike DNA-based immunization in rabbits elicited IgG avidity maturation and high neutralizing antibody responses against SARS-CoV-2
HHM da Costa, DJB Orts, AD Moura, AN Duarte-Neto… - Viruses, 2023 - mdpi.com
Neutralizing antibodies (nAbs) are a critical part of coronavirus disease 2019 (COVID-19)
research as they are used to gain insight into the immune response to severe acute …
research as they are used to gain insight into the immune response to severe acute …
Vaccine candidates against arenavirus infections
T Saito, RA Reyna, S Taniguchi, K Littlefield… - Vaccines, 2023 - mdpi.com
The viral family Arenaviridae contains several members that cause severe, and often lethal,
diseases in humans. Several highly pathogenic arenaviruses are classified as Risk Group 4 …
diseases in humans. Several highly pathogenic arenaviruses are classified as Risk Group 4 …
Biologics for dengue prevention: up-to-date
AT Waickman, K Newell, TP Endy… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Dengue is a worsening global public health problem. The vector-viral-host
interactions driving the pathogenesis of dengue are multi-dimensional. Sequential dengue …
interactions driving the pathogenesis of dengue are multi-dimensional. Sequential dengue …
Conjugation of Multiple Proteins Onto the Surface of PLGA/Lipid Hybrid Nanoparticles
Nanoparticles are increasingly being used in the development of vaccines for disease
prevention or treatment. Recent research has demonstrated that conjugating a protein onto …
prevention or treatment. Recent research has demonstrated that conjugating a protein onto …
Lassa virus infection: a summary for clinicians
V Raabe, AK Mehta, JD Evans, A Beitscher… - International Journal of …, 2022 - Elsevier
Abstract Objectives This summary on Lassa virus (LASV) infection and Lassa fever disease
(LF) was developed from a clinical perspective to provide clinicians with a condensed …
(LF) was developed from a clinical perspective to provide clinicians with a condensed …
Prospects of Lassa fever candidate vaccines
BI Ademusire, K Wieczorek, AT Alonge, A Rajen… - African Journal of …, 2022 - ajol.info
Ademusire et al., Afr., J. Infect. Dis. (2022) 16 (2S) 46 -58 https://doi.org/10.21010/Ajid v16i2S.6
PROSPECTS OF LASSA FEVER Page 1 Ademusire et al., Afr., J. Infect. Dis. (2022) 16 (2S) 46 …
PROSPECTS OF LASSA FEVER Page 1 Ademusire et al., Afr., J. Infect. Dis. (2022) 16 (2S) 46 …
Role of vaccination in patients with human monkeypox virus and its cardiovascular manifestations
KU Maqbool, MT Akhtar, S Ayub… - Annals of Medicine …, 2024 - journals.lww.com
Human monkeypox, caused by the monkeypox virus (MPXV), is an emerging infectious
disease with the potential for human-to-human transmission and diverse clinical …
disease with the potential for human-to-human transmission and diverse clinical …
Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease
Lassa fever virus (LASV), a member of the Arenavirus family, is the etiological agent of
Lassa fever, a severe hemorrhagic disease that causes considerable morbidity and mortality …
Lassa fever, a severe hemorrhagic disease that causes considerable morbidity and mortality …